Kinney Drugs files antitrust complaint against drugmakers over Glumetza
MLex Summary: Kinney Drugs filed a complaint against Bausch Health Companies, Assertio Therapeutics and others alleging that they engaged in an illegal pay-for-delay agreement concerning the diabetes drug Glumetza, resulting in higher prices. It...To view the full article, register now.
Already a subscriber? Click here to view full article